Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial-Reference-Cited by-同舟云学术

Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial

Published:2021-04-13 Issue:3 Volume:52 Page:797-807
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Verdoia M.^ORCID,Suryapranata H.,Damen S.,Camaro C.,Benit E.,Barbieri L.,Rasoul S.,Liew H. B.,Polad J.,Ahmad W. A. W.,Zambahari R.,Lalmand J.,van der Schaaf R. J.,Koh T. H.,Timmermans P,Dilling-Boer D.,Veenstra L. F.,van’t Hof A. W. J.,Lee S. W. L.,Roolvink V.,Ligtenberg E.,Postma S.,Kolkman E. J. J.,Brouwer M. A.,Kedhi E.,De Luca G.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

https://link.springer.com/content/pdf/10.1007/s11239-021-02439-x.pdf

Reference48 articles.

1. Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Marino P, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS) (2015) Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease. Nutr Metab Cardiovasc Dis 25(5):464–470

2. Barbieri L, Verdoia M, Schaffer A, Marino P, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS) (2015) Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: a single-centre study. Atherosclerosis 241(1):241

3. Barbieri L, Verdoia M, Nardin M, Marino P, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS) (2017) Gender difference in the risk of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous coronary intervention. Angiology 68(6):542–546

4. Cenko E, Yoon J, Kedev S, Stankovic G, Vasiljevic Z, Krljanac G, Kalpak O, Ricci B, Milicic D, Manfrini O, van der Schaar M, Badimon L, Bugiardini R (2018) Sex differences in outcomes after STEMI: effect modification by treatment strategy and age. JAMA Intern Med 178(5):632–639

5. De Luca G, Gibson CM, Gyöngyösi M, Zeymer U, Dudek D, Arntz HR, Bellandi F, Maioli M, Noc M, Zorman S, Gabriel HM, Emre A, Cutlip D, Rakowski T, Huber K, van’t Hof AW (2010) Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. J Thromb Thrombolysis 30(3):342–346. https://doi.org/10.1007/s11239-010-0451-y

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex disparity of DAPT noncompliance in patients with left main stem PCI with DES;Medicine;2024-06-28

2. Strategies for chronic coronary disease: A brief guide for clinicians;npj Cardiovascular Health;2024-06-04

3. Sex-Based Outcomes of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis;Drugs;2024-05-29

4. Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review;Journal of Clinical Medicine;2023-11-17

5. Gender differences in efficacy and safety of antiplatelet strategies for acute coronary syndromes;Expert Opinion on Drug Safety;2023-08-03